CN115521781B - A carbon quantum dot with high fluorescence performance for detecting oxytocin and its preparation method - Google Patents
A carbon quantum dot with high fluorescence performance for detecting oxytocin and its preparation method Download PDFInfo
- Publication number
- CN115521781B CN115521781B CN202211121946.4A CN202211121946A CN115521781B CN 115521781 B CN115521781 B CN 115521781B CN 202211121946 A CN202211121946 A CN 202211121946A CN 115521781 B CN115521781 B CN 115521781B
- Authority
- CN
- China
- Prior art keywords
- oxytocin
- carbon quantum
- solution
- quantum dot
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 title claims abstract description 120
- 101800000989 Oxytocin Proteins 0.000 title claims abstract description 120
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 title claims abstract description 120
- 229960001723 oxytocin Drugs 0.000 title claims abstract description 120
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 title claims abstract description 108
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 title claims abstract 24
- 238000001514 detection method Methods 0.000 claims abstract description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 238000006243 chemical reaction Methods 0.000 claims abstract description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 13
- 239000008367 deionised water Substances 0.000 claims abstract description 11
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 11
- 238000001027 hydrothermal synthesis Methods 0.000 claims abstract description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 7
- 238000001816 cooling Methods 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 102
- 239000012086 standard solution Substances 0.000 claims description 48
- 230000008859 change Effects 0.000 claims description 23
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical group C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims description 22
- 230000005284 excitation Effects 0.000 claims description 13
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims description 11
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims description 11
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims description 11
- 229960001285 quercetin Drugs 0.000 claims description 11
- 235000005875 quercetin Nutrition 0.000 claims description 11
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical group NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 5
- 238000000295 emission spectrum Methods 0.000 claims description 2
- 238000001228 spectrum Methods 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 102400000050 Oxytocin Human genes 0.000 description 96
- 238000002189 fluorescence spectrum Methods 0.000 description 7
- 230000002452 interceptive effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000000502 dialysis Methods 0.000 description 6
- 239000012528 membrane Substances 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000003797 Neuropeptides Human genes 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000010238 Uterine Inertia Diseases 0.000 description 1
- 206010046763 Uterine atony Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000002173 high-resolution transmission electron microscopy Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- XNOPRXBHLZRZKH-MQYCRUOZSA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1C(CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-MQYCRUOZSA-N 0.000 description 1
- 229940082408 oxytocin injection Drugs 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 238000006257 total synthesis reaction Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/65—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing carbon
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/0883—Arsenides; Nitrides; Phosphides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Optics & Photonics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Composite Materials (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
本发明公开了一种用于缩宫素检测高荧光性能碳量子点及其制备方法和应用,其制备方法包括以下步骤:将碳源、氮源和去离子水混合均匀,然后进行水热反应,制得反应溶液;冷却后,依次经过滤、透析、冷冻干燥,制得用于缩宫素检测高荧光性能碳量子点。本发明通过水热反应,得到氮掺杂的发黄绿色荧光的碳量子点,其荧光性能好,水溶性极佳,用于缩宫素的测定,具有操作简便快速、检测限低和准确度高的优势。本发明涉及药物含量检测技术领域,本发明解决了现有技术中缩宫素含量检测的方法操作复杂和准确度不高的问题。
The invention discloses a carbon quantum dot with high fluorescence performance for detecting oxytocin and its preparation method and application. The preparation method comprises the following steps: uniformly mixing a carbon source, a nitrogen source and deionized water, and then performing a hydrothermal reaction , to prepare a reaction solution; after cooling, successively filter, dialyze and freeze-dry to prepare carbon quantum dots with high fluorescence performance for detecting oxytocin. The invention obtains nitrogen-doped yellow-green fluorescent carbon quantum dots through hydrothermal reaction, which has good fluorescence performance and excellent water solubility, and is used for the determination of oxytocin, and has the advantages of simple and fast operation, low detection limit and high accuracy. high advantage. The invention relates to the technical field of drug content detection, and solves the problems of complicated operation and low accuracy of the method for detecting oxytocin content in the prior art.
Description
技术领域technical field
本发明涉及药物含量检测技术领域,具体涉及一种用于缩宫素检测高荧光性能碳量子点及其制备方法。The invention relates to the technical field of drug content detection, in particular to a carbon quantum dot with high fluorescence performance for detecting oxytocin and a preparation method thereof.
背景技术Background technique
缩宫素是由9个氨基酸组成的神经肽(Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-HN2),能够促进分娩和乳汁分泌,由猪、牛脑垂体中提取制得,也可采用全合成制备,临床上用于引产、催产、产后及流产后因宫缩乏力或缩复不良而引起的子宫出血。目前,缩宫素的测定方法主要有生物活性测定法、HPLC法、LC/MS法和免疫分析法;其中,生物活性测定法操作复杂,测定结果易受动物个体差异和人为操作误差的影响;HPLC和LC/MS需要仪器支持,且耗时长,成本高;免疫分析快速、灵敏,但准确性不高。因此,迫切需要建立一种用于缩宫素原料、制剂或临床使用药物中缩宫素浓度的快速、灵敏和准确的分析测定方法。Oxytocin is a neuropeptide composed of 9 amino acids (Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-HN2), which can promote childbirth and milk secretion. It is extracted from the pituitary gland of pigs and cattle. It can also be prepared by total synthesis, and it is clinically used for uterine bleeding caused by uterine atony or poor contraction after labor induction, oxytocin, postpartum and abortion. At present, the determination methods of oxytocin mainly include biological activity assay, HPLC method, LC/MS method and immunoassay method; among them, the biological activity assay method is complicated to operate, and the determination results are easily affected by individual animal differences and human error; HPLC and LC/MS require instrument support, and are time-consuming and costly; immunoassays are fast and sensitive, but the accuracy is not high. Therefore, there is an urgent need to establish a rapid, sensitive and accurate analytical method for the concentration of oxytocin in oxytocin raw materials, preparations or clinically used drugs.
发明内容Contents of the invention
为了解决上述技术问题,本发明的目的是提供一种用于缩宫素检测高荧光性能碳量子点及其制备方法和应用,以解决现有技术中缩宫素含量检测的方法操作复杂和准确度不高的问题。In order to solve the above technical problems, the object of the present invention is to provide a carbon quantum dot with high fluorescence performance for oxytocin detection and its preparation method and application, so as to solve the complicated and accurate operation of the method for detecting oxytocin content in the prior art low-level problem.
本发明解决上述技术问题的技术方案如下:提供一种用于缩宫素检测高荧光性能碳量子点的制备方法,包括以下步骤:The technical solution of the present invention to solve the above-mentioned technical problems is as follows: a method for preparing carbon quantum dots with high fluorescence performance for oxytocin detection is provided, comprising the following steps:
(1)将碳源、氮源和去离子水混合均匀,然后进行水热反应,制得反应溶液;(1) Mix carbon source, nitrogen source and deionized water evenly, then carry out hydrothermal reaction, make reaction solution;
(2)将步骤(1)制得的反应溶液冷却后,依次经过滤、透析、冷冻干燥,制得用于缩宫素检测高荧光性能碳量子点。(2) After the reaction solution prepared in step (1) is cooled, it is successively filtered, dialyzed and freeze-dried to prepare carbon quantum dots with high fluorescence performance for detecting oxytocin.
本发明的有益效果为:本发明通过水热反应,得到氮掺杂的发黄绿色荧光的碳量子点,其荧光性能好,水溶性极佳,用于缩宫素的测定,具有操作简便快速、检测限低和准确度高的优势。The beneficial effects of the present invention are: the present invention obtains nitrogen-doped yellow-green fluorescent carbon quantum dots through hydrothermal reaction, which has good fluorescence performance and excellent water solubility, and is used for the determination of oxytocin, and has the advantages of simple and fast operation , low detection limit and high accuracy.
在上述技术方案的基础上,本发明还可以做如下改进:On the basis of above-mentioned technical scheme, the present invention can also be improved as follows:
进一步,步骤(1)中,碳源、氮源和去离子水的摩尔体积比为0.5mmol:0.25-2mmol:10-25mL。Further, in step (1), the molar volume ratio of carbon source, nitrogen source and deionized water is 0.5mmol:0.25-2mmol:10-25mL.
进一步,步骤(1)中,碳源为槲皮素。Further, in step (1), the carbon source is quercetin.
进一步,步骤(1)中,氮源为邻苯二胺。Further, in step (1), the nitrogen source is o-phenylenediamine.
进一步,步骤(1)中,于160-240℃条件下水热反应4-8h。Further, in step (1), hydrothermal reaction is carried out at 160-240° C. for 4-8 hours.
进一步,步骤(2)中,将反应溶液经孔径为0.2-0.24μm的膜过滤。Further, in step (2), the reaction solution is filtered through a membrane with a pore size of 0.2-0.24 μm.
进一步,步骤(2)中,将反应溶液经孔径为0.22μm的膜过滤。Further, in step (2), the reaction solution is filtered through a membrane with a pore size of 0.22 μm.
进一步,步骤(2)中,于截留分子量为1000-5000Da条件下透析12-48h。Further, in step (2), dialyze for 12-48 hours under the condition of a molecular weight cut-off of 1000-5000 Da.
本发明还提供上述用于缩宫素检测高荧光性能碳量子点的制备方法制得的碳量子点。The present invention also provides carbon quantum dots prepared by the method for preparing carbon quantum dots with high fluorescence performance for detecting oxytocin.
本发明还提供上述用于缩宫素检测高荧光性能碳量子点在缩宫素含量检测方面的应用。The present invention also provides the application of the above-mentioned carbon quantum dot with high fluorescence performance for detecting oxytocin in the detection of oxytocin content.
一种缩宫素含量的检测方法,包括以下步骤:A detection method for oxytocin content, comprising the following steps:
(1)将上述的用于缩宫素检测高荧光性能碳量子点和水混合,制得碳量子点溶液;(1) The above-mentioned carbon quantum dots with high fluorescence performance for oxytocin detection are mixed with water to prepare a carbon quantum dot solution;
(2)在步骤(1)制得的碳量子点溶液中,分别加入不同浓度的缩宫素标准溶液,以460nm为激发波长,分别测定标准溶液加入前和加入后碳量子点溶液的荧光发射光谱,得到标准溶液加入后碳量子点溶液相对于标准溶液加入前碳量子点溶液在最大发射波长处的荧光强度变化值;(2) in the carbon quantum dot solution that step (1) makes, add the oxytocin standard solution of different concentrations respectively, take 460nm as the excitation wavelength, measure the fluorescence emission of the carbon quantum dot solution before and after adding the standard solution respectively Spectrum, after the standard solution is added, the carbon quantum dot solution is obtained relative to the fluorescence intensity change value of the carbon quantum dot solution at the maximum emission wavelength before the standard solution is added;
(3)根据步骤(2)得到的荧光强度的变化值和对应的缩宫素标准溶液的浓度,绘制标准曲线,得到线性方程;(3) According to the change value of the fluorescent intensity obtained in step (2) and the concentration of the corresponding oxytocin standard solution, draw a standard curve to obtain a linear equation;
(4)在步骤(1)制得的碳量子点溶液中,加入待检测缩宫素溶液,以460nm为激发波长,分别测定待检测缩宫素溶液加入前和加入后碳量子点溶液的荧光发射光谱,得到待检测缩宫素溶液加入后碳量子点溶液相对于待检测缩宫素溶液加入前碳量子点溶液在最大发射波长处的荧光强度变化值,代入线性方程,得到待检测缩宫素溶液的浓度。(4) In the carbon quantum dot solution prepared in step (1), add the oxytocin solution to be detected, and use 460nm as the excitation wavelength to measure the fluorescence of the carbon quantum dot solution before and after adding the oxytocin solution to be detected respectively Emission spectrum, obtain the change value of the fluorescence intensity of the carbon quantum dot solution at the maximum emission wavelength of the carbon quantum dot solution after the oxytocin solution to be detected is added relative to the carbon quantum dot solution before the oxytocin solution to be detected is added, and substitute into the linear equation to obtain the oxytocin solution to be detected concentration of the solution.
进一步,步骤(1)中,碳量子点溶液的浓度为0.05-1.5mg/mL。Further, in step (1), the concentration of the carbon quantum dot solution is 0.05-1.5 mg/mL.
进一步,步骤(1)中,碳量子点溶液的浓度为0.5mg/mL。Further, in step (1), the concentration of the carbon quantum dot solution is 0.5 mg/mL.
进一步,步骤(2)中,碳量子点溶液与缩宫素标准溶液的体积比为1:0.5-2。Further, in step (2), the volume ratio of the carbon quantum dot solution to the oxytocin standard solution is 1:0.5-2.
进一步,步骤(2)中,碳量子点溶液与缩宫素标准溶液的体积比为1:1。Further, in step (2), the volume ratio of the carbon quantum dot solution to the oxytocin standard solution is 1:1.
进一步,步骤(2)中,不同缩宫素标准溶液的浓度分别为0.2IU/mL、0.36IU/mL、0.4IU/mL、0.6IU/mL、0.8IU/mL、1.2IU/mL、1.6IU/mL、2IU/mL、3IU/mL、4IU/mL、5IU/mL、6IU/mL、7IU/mL、8IU/mL、9IU/mL和10IU/mL。Further, in step (2), the concentrations of different oxytocin standard solutions are 0.2IU/mL, 0.36IU/mL, 0.4IU/mL, 0.6IU/mL, 0.8IU/mL, 1.2IU/mL, 1.6IU /mL, 2IU/mL, 3IU/mL, 4IU/mL, 5IU/mL, 6IU/mL, 7IU/mL, 8IU/mL, 9IU/mL, and 10IU/mL.
进一步,步骤(3)中,缩宫素标准溶液的浓度在0.2-5IU/mL范围内,线性方程为y=29298x+17654,R2=0.9957,其中,y为荧光强度的变化值,x为缩宫素标准溶液的浓度,R是线性拟合常数。Further, in step (3), the concentration of oxytocin standard solution is in the range of 0.2-5IU/mL, the linear equation is y=29298x+17654, R 2 =0.9957, wherein, y is the change value of fluorescence intensity, x is Concentration of oxytocin standard solution, R is a linear fitting constant.
进一步,步骤(3)中,缩宫素标准溶液的浓度在5-10IU/mL范围内线性方程为y=6894x+127986,R2=0.9928,其中,y为荧光强度的变化值,x为缩宫素标准溶液的浓度,R是线性拟合常数。Further, in step (3), the linear equation for the concentration of oxytocin standard solution in the range of 5-10IU/mL is y=6894x+127986, R 2 =0.9928, wherein, y is the change value of fluorescence intensity, x is the contraction value Concentration of uterine standard solution, R is a linear fitting constant.
进一步,步骤(4)中,缩宫素的检测限为0.0196IU/mL。Further, in step (4), the detection limit of oxytocin is 0.0196IU/mL.
进一步,检测限LOD通过以下方法计算:将步骤(2)中标准溶液加入前碳量子点溶液的荧光强度重复测定11次,计算空白荧光强度的标准差,根据步骤(3)标准曲线得到标准曲线斜率,以信噪比S/N=3,用下式计算检测限LOD:Further, the detection limit LOD is calculated by the following method: the fluorescence intensity of the carbon quantum dot solution before the standard solution is added in the step (2) is repeatedly measured 11 times, the standard deviation of the blank fluorescence intensity is calculated, and the standard curve is obtained according to the standard curve of the step (3) Slope, with signal-to-noise ratio S/N=3, use the following formula to calculate the detection limit LOD:
LOD=3×空白荧光强度的标准差/标准曲线斜率LOD=3×Standard deviation of blank fluorescence intensity/Slope of standard curve
本发明具有以下有益效果:The present invention has the following beneficial effects:
1、本发明采用的碳源为槲皮素,很多植物中含有丰富的槲皮素,资源丰富、低廉易得;本发明采用水为反应溶剂,一步水热法合成,操作过程简便、绿色环保,经济高效,具有十分重要的社会意义。1. The carbon source used in the present invention is quercetin, which is rich in quercetin in many plants, and is rich in resources, cheap and easy to obtain; the present invention uses water as the reaction solvent, and is synthesized by a one-step hydrothermal method, and the operation process is simple and environmentally friendly. , economical and efficient, has very important social significance.
2、与传统的基于有机染料的传感探针相比,碳量子点作为荧光团的特性更优越,其不存在光漂白和毒性问题,表面羟基、羧基、羰基、环氧基等官能团的存在,赋予碳量子点在水中的溶解性,同时,这些基团为量子点的表面功能化铺平了道路,并提供了对目标分析物的选择性。2. Compared with traditional sensing probes based on organic dyes, carbon quantum dots have superior characteristics as fluorophores. They do not have photobleaching and toxicity problems, and the presence of functional groups such as hydroxyl, carboxyl, carbonyl, and epoxy groups on the surface , endow carbon quantum dots with solubility in water, meanwhile, these groups pave the way for surface functionalization of quantum dots and provide selectivity for target analytes.
3、本发明以简单易得的槲皮素为原料掺杂多氨基小分子,制备得到高荧光性能的碳量子点,并成功将其用于缩宫素的含量测定,本发明的测定方法具有构建方便、灵敏度高、特异性好和使用方便等优势,可应用于缩宫素原料及其制剂、以及临床使用药物中缩宫素浓度的测定。3. The present invention uses simple and easy-to-obtain quercetin as a raw material doped with polyamino small molecules to prepare carbon quantum dots with high fluorescence performance, and successfully uses it for the determination of oxytocin content. The assay method of the present invention has The method has the advantages of convenient construction, high sensitivity, good specificity and convenient use, and can be applied to the determination of oxytocin raw materials and preparations thereof, as well as the concentration of oxytocin in clinically used drugs.
附图说明Description of drawings
图1为实施例1制得的碳量子点的高分辨透射电镜图;Fig. 1 is the high-resolution transmission electron microscope figure of the carbon quantum dot that embodiment 1 makes;
图2为实施例1制得的碳量子点的粒径分布图;Fig. 2 is the particle size distribution figure of the carbon quantum dots that embodiment 1 makes;
图3为实施例1制得的碳量子点的红外光谱图;Fig. 3 is the infrared spectrogram of the carbon quantum dot that embodiment 1 makes;
图4为实施例1制得的碳量子点的紫外光谱图;Fig. 4 is the ultraviolet spectrogram of the carbon quantum dot that embodiment 1 makes;
图5为实施例1制得的碳量子点的荧光光谱图;Fig. 5 is the fluorescence spectrogram of the carbon quantum dot that embodiment 1 makes;
图6为实施例1制得的碳量子点的光稳定性测试图;Fig. 6 is the photostability test figure of the carbon quantum dot that embodiment 1 makes;
图7为实施例1制得的碳量子点的荧光强度和缩宫素浓度的线性关系图(0.2-5IU/mL);Fig. 7 is the linear relationship diagram (0.2-5IU/mL) of the fluorescence intensity of the carbon quantum dots prepared in Example 1 and the concentration of oxytocin;
图8为实施例1制得的碳量子点的荧光强度和缩宫素浓度的线性关系图(5-10IU/mL)。Fig. 8 is a graph showing the linear relationship between the fluorescence intensity of the carbon quantum dots prepared in Example 1 and the concentration of oxytocin (5-10 IU/mL).
具体实施方式Detailed ways
以下结合附图对本发明的原理和特征进行描述,所举实例只用于解释本发明,并非用于限定本发明的范围。实施例中未注明具体条件者,按照常规条件或制造商建议的条件进行。所用试剂或仪器未注明生产厂商者,均为可以通过市售购买获得的常规产品。The principles and features of the present invention are described below in conjunction with the accompanying drawings, and the examples given are only used to explain the present invention, and are not intended to limit the scope of the present invention. Those who do not indicate the specific conditions in the examples are carried out according to the conventional conditions or the conditions suggested by the manufacturer. The reagents or instruments used were not indicated by the manufacturer, and they were all conventional products that could be purchased from the market.
实施例1:Example 1:
一种用于缩宫素检测高荧光性能碳量子点,其制备方法包括以下步骤:A carbon quantum dot with high fluorescence performance for oxytocin detection, its preparation method comprises the following steps:
(1)将槲皮素、邻苯二胺和去离子水混合均匀,然后于220℃条件下水热反应6h,制得反应溶液;其中,槲皮素、邻苯二胺和去离子水的摩尔体积比为0.5mmol:1.5mmol:20mL;(1) Mix quercetin, o-phenylenediamine, and deionized water evenly, and then conduct a hydrothermal reaction at 220°C for 6 hours to prepare a reaction solution; wherein, the moles of quercetin, o-phenylenediamine, and deionized water The volume ratio is 0.5mmol: 1.5mmol: 20mL;
(2)将步骤(1)制得的反应溶液冷却后,经孔径为0.22μm的膜过滤,滤液转移至截留分子量为2000Da透析袋中透析24h,冷冻干燥,制得用于缩宫素检测高荧光性能碳量子点。(2) After the reaction solution prepared in step (1) is cooled, it is filtered through a membrane with a pore size of 0.22 μm, and the filtrate is transferred to a dialysis bag with a molecular weight cut-off of 2000 Da for dialysis for 24 hours and then freeze-dried to obtain a high Fluorescent properties of carbon quantum dots.
一种缩宫素含量的检测方法,包括以下步骤:A detection method for oxytocin content, comprising the following steps:
(1)将制得的用于缩宫素检测高荧光性能碳量子点和水混合,制得浓度为0.5mg/mL碳量子点溶液;(1) The prepared carbon quantum dots with high fluorescence performance for oxytocin detection are mixed with water to prepare a carbon quantum dot solution with a concentration of 0.5 mg/mL;
(2)取100μL步骤(1)制得的碳量子点溶液,分别加入100μL不同浓度的缩宫素标准溶液(0.2IU/mL、0.36IU/mL、0.4IU/mL、0.6IU/mL、0.8IU/mL、1.2IU/mL、1.6IU/mL、2IU/mL、3IU/mL、4IU/mL、5IU/mL、6IU/mL、7IU/mL、8IU/mL、9IU/mL、10IU/mL),以460nm为激发波长,分别测定标准溶液加入前和加入后碳量子点溶液的荧光发射光谱,得到标准溶液加入后碳量子点溶液相对于标准溶液加入前碳量子点溶液在最大发射波长542nm处的荧光强度变化值;(2) Take 100 μL of the carbon quantum dot solution prepared in step (1), and add 100 μL of different concentrations of oxytocin standard solutions (0.2IU/mL, 0.36IU/mL, 0.4IU/mL, 0.6IU/mL, 0.8 IU/mL, 1.2IU/mL, 1.6IU/mL, 2IU/mL, 3IU/mL, 4IU/mL, 5IU/mL, 6IU/mL, 7IU/mL, 8IU/mL, 9IU/mL, 10IU/mL) , taking 460nm as the excitation wavelength, measure the fluorescence emission spectrum of the carbon quantum dot solution before and after adding the standard solution respectively, obtain the carbon quantum dot solution after the standard solution is added relative to the carbon quantum dot solution before the standard solution adds at the maximum emission wavelength 542nm place The change value of the fluorescence intensity;
(3)根据步骤(2)得到的荧光强度的变化值和对应的缩宫素标准溶液的浓度,绘制标准曲线,得到线性方程;(3) According to the change value of the fluorescent intensity obtained in step (2) and the concentration of the corresponding oxytocin standard solution, draw a standard curve to obtain a linear equation;
其中,缩宫素标准溶液的浓度在0.2-5IU/mL范围内,线性方程为y=29298x+17654,R2=0.9957,其中,y为荧光强度的变化值,x为缩宫素标准溶液的浓度,R是线性拟合常数(见图7,F0表示未加入缩宫素时荧光强度,F表示加入缩宫素时的荧光强度);Wherein, the concentration of oxytocin standard solution is in the range of 0.2-5IU/mL, the linear equation is y=29298x+17654, R 2 =0.9957, wherein, y is the change value of fluorescence intensity, x is the oxytocin standard solution Concentration, R is a linear fitting constant (see Figure 7, F 0 represents the fluorescence intensity when oxytocin is not added, and F represents the fluorescence intensity when oxytocin is added);
缩宫素标准溶液的浓度在5-10IU/mL范围内线性方程为y=6894x+127986,R2=0.9928,其中,y为荧光强度的变化值,x为缩宫素标准溶液的浓度,R是线性拟合常数(见图8,F0表示未加入缩宫素时荧光强度,F表示加入缩宫素时的荧光强度);The linear equation of the concentration of oxytocin standard solution in the range of 5-10IU/mL is y=6894x+127986, R 2 =0.9928, wherein, y is the change value of fluorescence intensity, x is the concentration of oxytocin standard solution, R is a linear fitting constant (see Figure 8, F 0 represents the fluorescence intensity when oxytocin is not added, and F represents the fluorescence intensity when oxytocin is added);
(4)取100μL步骤(1)制得的碳量子点溶液,加入100μL待检测缩宫素溶液(已知浓度为1.67IU/mL,平行测定6次),以460nm为激发波长,分别测定待检测缩宫素溶液加入前和加入后碳量子点溶液的荧光发射光谱,得到待检测缩宫素溶液加入后碳量子点溶液相对于待检测缩宫素溶液加入前碳量子点溶液在最大发射波长542nm处的荧光强度变化值,代入线性方程,得到待检测缩宫素溶液的浓度为1.69IU/mL。(4) Take 100 μL of the carbon quantum dot solution prepared in step (1), add 100 μL of the oxytocin solution to be detected (the known concentration is 1.67IU/mL, and measure 6 times in parallel), and use 460nm as the excitation wavelength to measure the oxytocin solution to be tested respectively. Detect the fluorescence emission spectrum of the carbon quantum dot solution before and after adding the oxytocin solution, and obtain the maximum emission wavelength of the carbon quantum dot solution after the oxytocin solution is added relative to the carbon quantum dot solution before the oxytocin solution is added. The change value of the fluorescence intensity at 542nm was substituted into the linear equation, and the concentration of the oxytocin solution to be detected was 1.69IU/mL.
实施例2:Example 2:
一种用于缩宫素检测高荧光性能碳量子点,其制备方法包括以下步骤:A carbon quantum dot with high fluorescence performance for oxytocin detection, its preparation method comprises the following steps:
(1)将槲皮素、邻苯二胺和去离子水混合均匀,然后于160℃条件下水热反应8h,制得反应溶液;其中,槲皮素、邻苯二胺和去离子水的摩尔体积比为0.5mmol:0.25mmol:10mL;(1) Mix quercetin, o-phenylenediamine and deionized water evenly, and then conduct a hydrothermal reaction at 160°C for 8 hours to prepare a reaction solution; wherein, the moles of quercetin, o-phenylenediamine and deionized water The volume ratio is 0.5mmol: 0.25mmol: 10mL;
(2)将步骤(1)制得的反应溶液冷却后,经孔径为0.22μm的膜过滤,滤液转移至截留分子量为1000Da透析袋中透析48h,冷冻干燥,制得用于缩宫素检测高荧光性能碳量子点。(2) After the reaction solution prepared in step (1) is cooled, it is filtered through a membrane with a pore size of 0.22 μm, and the filtrate is transferred to a dialysis bag with a molecular weight cut-off of 1000 Da for dialysis for 48 hours and freeze-dried to obtain a high Fluorescent properties of carbon quantum dots.
一种缩宫素含量的检测方法,包括以下步骤:A detection method for oxytocin content, comprising the following steps:
(1)将制得的用于缩宫素检测高荧光性能碳量子点和水混合,制得浓度为0.05mg/mL碳量子点溶液;(1) The prepared carbon quantum dots with high fluorescence performance for oxytocin detection are mixed with water to prepare a carbon quantum dot solution with a concentration of 0.05 mg/mL;
(2)取100μL步骤(1)制得的碳量子点溶液,分别加入50μL不同浓度的缩宫素标准溶液(0.2IU/mL、0.36IU/mL、0.4IU/mL、0.6IU/mL、0.8IU/mL、1.2IU/mL、1.6IU/mL、2IU/mL、3IU/mL、4IU/mL、5IU/mL、6IU/mL、7IU/mL、8IU/mL、9IU/mL、10IU/mL),以460nm为激发波长,分别测定标准溶液加入前和加入后碳量子点溶液的荧光发射光谱,得到标准溶液加入后碳量子点溶液相对于标准溶液加入前碳量子点溶液在最大发射波长542nm处的荧光强度变化值;(2) Take 100 μL of the carbon quantum dot solution prepared in step (1), and add 50 μL of different concentrations of oxytocin standard solutions (0.2IU/mL, 0.36IU/mL, 0.4IU/mL, 0.6IU/mL, 0.8 IU/mL, 1.2IU/mL, 1.6IU/mL, 2IU/mL, 3IU/mL, 4IU/mL, 5IU/mL, 6IU/mL, 7IU/mL, 8IU/mL, 9IU/mL, 10IU/mL) , taking 460nm as the excitation wavelength, measure the fluorescence emission spectrum of the carbon quantum dot solution before and after adding the standard solution respectively, obtain the carbon quantum dot solution after the standard solution is added relative to the carbon quantum dot solution before the standard solution adds at the maximum emission wavelength 542nm place The change value of the fluorescence intensity;
(3)根据步骤(2)得到的荧光强度的变化值和对应的缩宫素标准溶液的浓度,绘制标准曲线,得到线性方程;(3) According to the change value of the fluorescent intensity obtained in step (2) and the concentration of the corresponding oxytocin standard solution, draw a standard curve to obtain a linear equation;
其中,缩宫素标准溶液的浓度在0.2-5IU/mL范围内,线性方程为y=7333x+2235,R2=0.9908,其中,y为荧光强度的变化值,x为缩宫素标准溶液的浓度,R是线性拟合常数;Wherein, the concentration of the oxytocin standard solution is in the range of 0.2-5IU/mL, the linear equation is y=7333x+2235, R 2 =0.9908, wherein, y is the change value of the fluorescence intensity, x is the oxytocin standard solution Concentration, R is a linear fitting constant;
缩宫素标准溶液的浓度在5-10IU/mL范围内,线性方程为y=1518x+31106,R2=0.9878,其中,y为荧光强度的变化值,x为缩宫素标准溶液的浓度,R是线性拟合常数;The concentration of the oxytocin standard solution is in the range of 5-10IU/mL, the linear equation is y=1518x+31106, R 2 =0.9878, wherein, y is the change value of the fluorescence intensity, x is the concentration of the oxytocin standard solution, R is a linear fitting constant;
(4)取100μL步骤(1)制得的碳量子点溶液,加入50μL待检测缩宫素溶液(已知浓度为3.75IU/mL,平行测定6次),以460nm为激发波长,分别测定待检测缩宫素溶液加入前和加入后碳量子点溶液的荧光发射光谱,得到待检测缩宫素溶液加入后碳量子点溶液相对于待检测缩宫素溶液加入前碳量子点溶液在最大发射波长542nm处的荧光强度变化值,代入线性方程,得到待检测缩宫素溶液的浓度为3.7IU/mL。(4) Take 100 μL of the carbon quantum dot solution prepared in step (1), add 50 μL of the oxytocin solution to be detected (the known concentration is 3.75IU/mL, and measure 6 times in parallel), and use 460nm as the excitation wavelength to measure the oxytocin solution to be tested respectively. Detect the fluorescence emission spectrum of the carbon quantum dot solution before and after adding the oxytocin solution, and obtain the maximum emission wavelength of the carbon quantum dot solution after the oxytocin solution is added relative to the carbon quantum dot solution before the oxytocin solution is added. The change value of the fluorescence intensity at 542nm was substituted into the linear equation, and the concentration of the oxytocin solution to be detected was 3.7IU/mL.
实施例3:Example 3:
一种用于缩宫素检测高荧光性能碳量子点,其制备方法包括以下步骤:A carbon quantum dot with high fluorescence performance for oxytocin detection, its preparation method comprises the following steps:
(1)将槲皮素、邻苯二胺和去离子水混合均匀,然后于240℃条件下水热反应4h,制得反应溶液;其中,槲皮素、邻苯二胺和去离子水的摩尔体积比为0.5mmol:2mmol:25mL;(1) Mix quercetin, o-phenylenediamine and deionized water evenly, and then conduct a hydrothermal reaction at 240°C for 4 hours to prepare a reaction solution; wherein, the moles of quercetin, o-phenylenediamine and deionized water The volume ratio is 0.5mmol: 2mmol: 25mL;
(2)将步骤(1)制得的反应溶液冷却后,经孔径为0.22μm的膜过滤,滤液转移至截留分子量为5000Da透析袋中透析12h,冷冻干燥,制得用于缩宫素检测高荧光性能碳量子点。(2) After the reaction solution prepared in step (1) is cooled, it is filtered through a membrane with a pore size of 0.22 μm, and the filtrate is transferred to a dialysis bag with a molecular weight cut-off of 5000 Da for dialysis for 12 hours and freeze-dried to obtain a high Fluorescent properties of carbon quantum dots.
一种缩宫素含量的检测方法,包括以下步骤:A detection method for oxytocin content, comprising the following steps:
(1)将制得的用于缩宫素检测高荧光性能碳量子点和水混合,制得浓度为1.5mg/mL碳量子点溶液;(1) The prepared carbon quantum dots with high fluorescence performance for oxytocin detection are mixed with water to prepare a carbon quantum dot solution with a concentration of 1.5 mg/mL;
(2)取50μL步骤(1)制得的碳量子点溶液,分别加入100μL不同浓度的缩宫素标准溶液(0.2IU/mL、0.36IU/mL、0.4IU/mL、0.6IU/mL、0.8IU/mL、1.2IU/mL、1.6IU/mL、2IU/mL、3IU/mL、4IU/mL、5IU/mL、6IU/mL、7IU/mL、8IU/mL、9IU/mL、10IU/mL),以460nm为激发波长,分别测定标准溶液加入前和加入后碳量子点溶液的荧光发射光谱,得到标准溶液加入后碳量子点溶液相对于标准溶液加入前碳量子点溶液在最大发射波长542nm处的荧光强度变化值;(2) Take 50 μL of the carbon quantum dot solution prepared in step (1), and add 100 μL of different concentrations of oxytocin standard solutions (0.2IU/mL, 0.36IU/mL, 0.4IU/mL, 0.6IU/mL, 0.8 IU/mL, 1.2IU/mL, 1.6IU/mL, 2IU/mL, 3IU/mL, 4IU/mL, 5IU/mL, 6IU/mL, 7IU/mL, 8IU/mL, 9IU/mL, 10IU/mL) , taking 460nm as the excitation wavelength, measure the fluorescence emission spectrum of the carbon quantum dot solution before and after adding the standard solution respectively, obtain the carbon quantum dot solution after the standard solution is added relative to the carbon quantum dot solution before the standard solution adds at the maximum emission wavelength 542nm place The change value of the fluorescence intensity;
(3)根据步骤(2)得到的荧光强度的变化值和对应的缩宫素标准溶液的浓度,绘制标准曲线,得到线性方程;(3) According to the change value of the fluorescent intensity obtained in step (2) and the concentration of the corresponding oxytocin standard solution, draw a standard curve to obtain a linear equation;
其中,缩宫素标准溶液的浓度在0.2-5IU/mL范围内,线性方程为y=21382x+12486,R2=0.9943,其中,y为荧光强度的变化值,x为缩宫素标准溶液的浓度,R是线性拟合常数;Wherein, the concentration of the oxytocin standard solution is within the range of 0.2-5IU/mL, the linear equation is y=21382x+12486, R 2 =0.9943, wherein, y is the change value of the fluorescence intensity, and x is the oxytocin standard solution Concentration, R is a linear fitting constant;
缩宫素标准溶液的浓度在5-10IU/mL范围内线性方程为y=5625x+91977,R2=0.9937,其中,y为荧光强度的变化值,x为缩宫素标准溶液的浓度,R是线性拟合常数;The linear equation of the concentration of oxytocin standard solution in the range of 5-10IU/mL is y=5625x+91977, R 2 =0.9937, wherein, y is the change value of fluorescence intensity, x is the concentration of oxytocin standard solution, R is the linear fitting constant;
(4)取50μL步骤(1)制得的碳量子点溶液,加入100μL待检测缩宫素溶液(已知浓度为6.67IU/mL,平行测定6次),以460nm为激发波长,分别测定待检测缩宫素溶液加入前和加入后碳量子点溶液的荧光发射光谱,得到待检测缩宫素溶液加入后碳量子点溶液相对于待检测缩宫素溶液加入前碳量子点溶液在最大发射波长542nm处的荧光强度变化值,代入线性方程,得到待检测缩宫素溶液的浓度为6.91IU/mL。(4) Take 50 μL of the carbon quantum dot solution prepared in step (1), add 100 μL of the oxytocin solution to be detected (the known concentration is 6.67IU/mL, measured in parallel 6 times), and use 460nm as the excitation wavelength to measure the oxytocin solution to be detected respectively. Detect the fluorescence emission spectrum of the carbon quantum dot solution before and after adding the oxytocin solution, and obtain the maximum emission wavelength of the carbon quantum dot solution after the oxytocin solution is added relative to the carbon quantum dot solution before the oxytocin solution is added. The change value of the fluorescence intensity at 542nm was substituted into the linear equation, and the concentration of the oxytocin solution to be detected was 6.91IU/mL.
试验例Test case
实施例1-3制得的用于缩宫素检测高荧光性能碳量子点的表征和性能基本一致,下面以实施例1为例,进行如下检测。The characterization and performance of the carbon quantum dots with high fluorescence performance for the detection of oxytocin prepared in Examples 1-3 are basically the same. Taking Example 1 as an example, the following detection is carried out.
一、将实施例1制得的用于缩宫素检测高荧光性能碳量子点进行高分辨透射电镜、粒径、红外和紫外检测,结果见图1-4。1. The carbon quantum dots with high fluorescence performance for oxytocin detection prepared in Example 1 were subjected to high-resolution transmission electron microscopy, particle size, infrared and ultraviolet detection, and the results are shown in Figures 1-4.
由图1-2可知,合成的碳点粒径均匀,平均粒径为8.28nm。It can be seen from Figure 1-2 that the synthesized carbon dots have a uniform particle size, with an average particle size of 8.28nm.
由图3可知,3360cm-1和3031cm-1是氨基和羟基的伸缩振动峰,1621-1460cm-1是苯环骨架伸缩振动峰C=C,1276cm-1是苯环上C-N取代伸缩振动峰,745.64cm-1是邻二取代苯环上C-H伸缩振动峰,说明合成的碳点具有苯环骨架,表面具有羟基和氨基,大量极性羟基和氨基的存在使碳点具有良好的水溶性。It can be seen from Figure 3 that 3360cm -1 and 3031cm -1 are the stretching vibration peaks of amino and hydroxyl groups, 1621-1460cm -1 is the stretching vibration peak of the benzene ring skeleton C=C, and 1276cm -1 is the stretching vibration peak of CN substitution on the benzene ring. 745.64cm -1 is the CH stretching vibration peak on the ortho-disubstituted benzene ring, indicating that the synthesized carbon dots have a benzene ring skeleton, and the surface has hydroxyl and amino groups. The existence of a large number of polar hydroxyl groups and amino groups makes the carbon dots have good water solubility.
由图4可知,碳点溶液在280nm和230nm有最大吸收,进一步表明碳点具有共轭双键结构。It can be seen from Figure 4 that the carbon dot solution has maximum absorption at 280nm and 230nm, further indicating that the carbon dots have a conjugated double bond structure.
二、将实施例1制得的用于缩宫素检测高荧光性能碳量子点溶液进行荧光光谱检测,结果见图5。由图5可知,本碳量子点的最大激发光波长为460nm,最大发射波长为542nm。2. The carbon quantum dot solution with high fluorescence performance for oxytocin detection prepared in Example 1 was subjected to fluorescence spectrum detection, and the results are shown in FIG. 5 . It can be seen from FIG. 5 that the maximum excitation wavelength of the present carbon quantum dot is 460nm, and the maximum emission wavelength is 542nm.
三、将实施例1制得的用于缩宫素检测高荧光性能碳量子点溶液采用激发光460nm连续照射10h,其荧光信号见图6。由图6可知,表明本发明制备的碳点具有强的抗光漂白作用,具有较好的光稳定性。3. The carbon quantum dot solution with high fluorescence performance for oxytocin detection prepared in Example 1 was continuously irradiated for 10 h with an excitation light of 460 nm, and its fluorescence signal is shown in FIG. 6 . It can be seen from Fig. 6 that the carbon dots prepared by the present invention have strong photobleaching resistance and better photostability.
四、干扰物质对缩宫素测定结果的影响4. The influence of interfering substances on the determination results of oxytocin
将实施例1制得的用于缩宫素检测高荧光性能碳量子点配置成50μL碳量子点溶液(1mg/mL),加入100μL浓度为1IU/mL的缩宫素标准溶液(质量浓度为1.67ug/mL),再分别加入50μL水或不同干扰物质的水溶液(每组平行测定6次),以460nm为激发波长,分别测定加水和加入不同干扰物质后反应体系在最大发射波长542nm处的荧光强度;将加入干扰物质后反应体系的荧光强度与加水的反应体系的荧光强度进行对比,得到相对误差(%),结果见表1。The carbon quantum dots with high fluorescence performance for oxytocin detection prepared in Example 1 were configured into 50 μL carbon quantum dot solution (1 mg/mL), and 100 μL of oxytocin standard solution (mass concentration of 1.67 μL) was added with a concentration of 1 IU/mL ug/mL), and then add 50 μL of water or aqueous solutions of different interfering substances (6 times in parallel for each group), and use 460nm as the excitation wavelength to measure the fluorescence of the reaction system at the maximum emission wavelength of 542nm after adding water and adding different interfering substances. Intensity; the fluorescence intensity of the reaction system after adding the interfering substance is compared with the fluorescence intensity of the reaction system with water, and the relative error (%) is obtained. The results are shown in Table 1.
由表1可知,常见的干扰离子如水中常见的金属离子、缩宫素提取工艺中可能引入的各种氨基酸和缩宫素注射液中的辅料三氯叔丁醇对其测定结果均无影响(以相对误差在±5%以内,干扰物质对测定的影响可以忽略不计),说明该碳量子点对缩宫素有很好的选择性,测定时不受其他物质的干扰,可用于缩宫素的测定。As can be seen from Table 1, common interfering ions such as common metal ions in water, various amino acids that may be introduced in the extraction process of oxytocin and the adjuvant chlorobutanol in oxytocin injection have no effect on its determination results ( The relative error is within ±5%, and the influence of interfering substances on the determination can be ignored), indicating that the carbon quantum dots have good selectivity to oxytocin, and are not interfered by other substances during determination, and can be used for oxytocin determination.
表1干扰物质对测定结果的影响结果(n=6)Table 1 The influence of interfering substances on the measurement results (n=6)
五、准确度和精密度5. Accuracy and precision
将实施例1-3的测定结果进行回收率和精密度测定,结果见表2。由表2可知,本发明的碳量子点用于缩宫素含量检测的准确性和精密度良好。The measurement results of Examples 1-3 were carried out for recovery and precision measurement, and the results are shown in Table 2. It can be seen from Table 2 that the carbon quantum dots of the present invention have good accuracy and precision for detecting the content of oxytocin.
表2方法准确度和精密度的测定结果(n=6)Table 2 Measurement results of method accuracy and precision (n=6)
六、检出限6. Detection limit
将实施例1步骤(2)中标准溶液加入前碳量子点溶液的荧光强度重复测定11次,计算空白荧光强度的标准差,根据步骤(3)标准曲线得到标准曲线斜率,以信噪比S/N=3,用下式计算检测限LOD:The fluorescence intensity of the carbon quantum dot solution before the standard solution is added in the embodiment 1 step (2) is repeatedly measured 11 times, calculates the standard deviation of the blank fluorescence intensity, obtains the slope of the standard curve according to the step (3) standard curve, and uses the signal-to-noise ratio S /N=3, calculate the detection limit LOD with the following formula:
LOD=3×空白荧光强度的标准差/标准曲线斜率LOD=3×Standard deviation of blank fluorescence intensity/Slope of standard curve
可得,缩宫素的检测限为0.0196IU/mL。Available, the detection limit of oxytocin is 0.0196IU/mL.
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included in the protection of the present invention. within range.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211121946.4A CN115521781B (en) | 2022-09-15 | 2022-09-15 | A carbon quantum dot with high fluorescence performance for detecting oxytocin and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211121946.4A CN115521781B (en) | 2022-09-15 | 2022-09-15 | A carbon quantum dot with high fluorescence performance for detecting oxytocin and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115521781A CN115521781A (en) | 2022-12-27 |
CN115521781B true CN115521781B (en) | 2023-08-22 |
Family
ID=84698478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211121946.4A Active CN115521781B (en) | 2022-09-15 | 2022-09-15 | A carbon quantum dot with high fluorescence performance for detecting oxytocin and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115521781B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116730324B (en) * | 2023-06-20 | 2024-01-26 | 西北大学 | A near-infrared AIE carbon dot, its preparation method and its application in triple anti-counterfeiting and aluminum ion detection |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111793494A (en) * | 2020-07-24 | 2020-10-20 | 中国农业科学院郑州果树研究所 | A kind of fluorescent carbon dots with high water solubility and preparation method and application thereof |
-
2022
- 2022-09-15 CN CN202211121946.4A patent/CN115521781B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111793494A (en) * | 2020-07-24 | 2020-10-20 | 中国农业科学院郑州果树研究所 | A kind of fluorescent carbon dots with high water solubility and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN115521781A (en) | 2022-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | DNase I enzyme-aided fluorescence signal amplification based on graphene oxide-DNA aptamer interactions for colorectal cancer exosome detection | |
CN118530607A (en) | Fluorescent water-solvated conjugated polymers | |
US12180183B2 (en) | Water-soluble fluorescent probe and nanoparticals with aggregation-induced emission effect for ovarian cancer and preparation method and use thereof | |
CN115521781B (en) | A carbon quantum dot with high fluorescence performance for detecting oxytocin and its preparation method | |
CN110095443A (en) | A kind of fluorescent method detecting brain natriuretic peptide based on graphene oxide/aptamer | |
CN111334282A (en) | PTH rare earth detection kit, detection card, microspheres thereof, preparation method and detection method | |
CN109867611A (en) | A kind of for red wine and in vivo water-soluble two-photon hydrogen sulfide fluorescence probe and its preparation method and application of sulfurated hydrogen detection | |
CN104892541A (en) | Fluorescent probe for detecting gamma-glutamyl transpeptidase as well as preparation method and application of fluorescent probe | |
CN101344526A (en) | Fast and accurate prostatic cancer detection test paper strip and its preparation and application | |
CN111675674A (en) | A kind of AIE molecule and its synthesis method | |
CN110642839B (en) | Nano probe and preparation method and application thereof | |
CN115932248A (en) | Single-molecule immunoassay method based on aggregation-induced emission material | |
CN114605343A (en) | Fluorescent group LAN-OH, fluorescent sensor LAN-beta gal, preparation method and application thereof | |
CN112255212B (en) | Method for detecting H5N1 influenza A virus hemagglutinin | |
CN106526183A (en) | Preparation method and application of electrochemical luminescence immune sensor for potentiometric resolution of double tumor marker | |
CN112379107A (en) | Chemical luminescence immune detection kit for gastrin releasing peptide precursor and preparation method thereof | |
CN109020999A (en) | A kind of preparation and application of two pyroles near-infrared pH fluorescence probe of the boron of fluorine containing piperidyl | |
CN113075179A (en) | Method for detecting ketamine by using supramolecular fluorescent probe | |
JP2001208754A (en) | Composition for detecting biological specimen | |
CN104774606B (en) | Aqueous buffer solution detects the preparation method of the near infrared fluorescent probe of Avidin | |
CN107163068A (en) | A kind of novel fluorescence probe and preparation method thereof and the application in detection uric acid | |
CN107966425B (en) | A ratiometric fluorescent probe of morpholinoguanidine based on copper nanocluster/fluorescein complex | |
CN116003448A (en) | A BODIPY near-infrared fluorescent probe containing indoline polyene bonds for recognizing Aβ fibers and its preparation method | |
CN110806421A (en) | NMR detection method for PAMAM and guest small molecule interaction mode | |
CN114426572B (en) | Composite carbonized polymer dot and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |